Single-Cell Maps Reveal Genome Reorganization in Alzheimer’s Brain Cells

Researchers have identified a link between 3D genome reorganization and gene regulation disruption in Alzheimer's disease using single-cell multiomics. The study provides new insights into the molecular mechanisms of neurodegeneration.
Why it matters
Understanding the structural changes in the genome could lead to new diagnostic or therapeutic targets for Alzheimer's disease.
While Alzheimer’s disease is the most common cause of dementia, many of the molecular mechanisms that drive its progression remain poorly understood. While researchers have cataloged changes in gene activity across different brain cell types, a key unanswered question has been how the genome’s 3D organization influences those changes. Now, researchers have linked alterations in genome folding to disrupted gene regulation in Alzheimer’s disease, providing a new layer of insight into the biology of neurodegeneration.
The findings, published in Science in the paper “ Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer’s disease ,” were reported by researchers from Carnegie Mellon University’s School of Computer Science, the University of Pittsburgh School of Medicine, the University of Washington, and collaborating institutions. Using single-cell multiomics, spatial transcriptomics, and artificial intelligence (AI), the team generated a multiscale view connecting genome structure, gene expression, and tissue organization in Alzheimer’s disease.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in